Hairy Cell Leukemia (HCL) Follow‑Up Flow Panel
Use
A flow cytometry–based immunophenotyping assay intended for follow-up assessment in patients with known Hairy Cell Leukemia (HCL). It helps evaluate residual disease using markers indicative of HCL immunophenotype after treatment. Prior immunophenotyping (Standard or Extended Flow Panel) at NeoGenomics is strongly recommended to interpret residual disease assessment accurately. Clinical history including timing after treatment, prior flow cytometry or pathology reports, and CBC results are requested to improve diagnostic interpretation.
Special Instructions
Available in two levels of service: “Global” (includes full testing) and “Tech Only” (technical component). Clients declining full phenotyping and ordering a push‑to‑global panel must provide prior diagnostic materials (flow cytometry or pathology report and/or clinical history). For New York clients, date and time of collection must be provided. Submit recent CBC with blood or bone marrow aspirate specimens.
Limitations
Not provided.
New York Approved
Methodology
Cell-based / Cytometry (Other)
Biomarkers
Result Turnaround Time
24 hours
Related Documents
For more information, please review the documents below
Specimen
Bone Marrow
Volume
1-2 mL
Minimum Volume
Not provided
Container
EDTA; sodium heparin acceptable; lithium heparin or ACD not acceptable
Collection Instructions
Please provide recent CBC report
Storage Instructions
Refrigerate specimen; do not freeze; use cold pack not in direct contact
Causes for Rejection
Use of lithium heparin or ACD tubes; biopsy needles, blades, foreign objects in transport
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | Receive within 72 hours (48 hours for NY) |